InsidersTradesSigma
텔콘RF제약 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 텔콘RF제약 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 텔콘RF제약 has recorded 29 insider filings. Market capitalisation: €19.5bn. The latest transaction was disclosed on 30 June 2026 (Other). Among the most active insiders: 상상인저축은행. The full history is free.
29
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
10 ops.
Sell Volume
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,127 of 26,213 companies
30.1
score / 100
Value41
Quality19
FCF yld8.8%
Earn yld-75%
EV/EBITDA·
ROE-10%
Gross mgn24%
Net mgn-27%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 30 June 2026
Declarations29 total
25 of 29 declarations
About 텔콘RF제약
텔콘RF제약 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative pharmaceutical products.